| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-2 週間 |
| 被験者数 | 12 |
| 性別 | 男性 |
| 年齢 | 18-29 |
| 体型 | トレーニング中, 平均 |
この研究の注釈：
Supplementation of 20g colostrum daily for two weeks prior to a VO2 max training session, relative to placebo, failed to improve physical performance but was able to reduce the increase in intestinal permeability that occurs with high intensity exercise where body heat is elevated.
Supplementation of 20g colostrum daily for two weeks prior to a VO2 max training session, relative to placebo, failed to improve physical performance but was able to reduce the increase in intestinal permeability that occurs with high intensity exercise where body heat is elevated.
The increase in GLP-1 seen during exercise in placebo was attenuated with colostrum; other biomarkers (serum NPY, VIP, or ghrelin) were not affected.
Bovine Colostrum Supplementation During Running Training Increases Intestinal Permeability
| 効果 | 増加 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 30 |
| 性別 | 男性 |
| 年齢 | 18-29 |
| 体型 | トレーニング中, 平均 |
この研究の注釈：
Supplementation of 60g bovine colostrum (immunoglobulin content not disclosed) daily for eight weeks alongside thrice weekly aerobic training noted that, when subject to a 30 minute run to exhaustion, that colostrum was associated with an increase in intestinal permeability without any overt gastointestinal side effects.
Supplementation of 60g bovine colostrum (immunoglobulin content not disclosed) daily for eight weeks alongside thrice weekly aerobic training noted that, when subject to a 30 minute run to exhaustion, that colostrum was associated with an increase in intestinal permeability without any overt gastointestinal side effects.
No performance parameter was increased with supplementation.
研究の資金源に関する問題点：
Funded by Numico, producer of the colostrum produced used
Co-administration Of The Health Food Supplement, Bovine Colostrum, Reduces The Acute Non-steroidal Anti-inflammatory Drug-induced Increase In Intestinal Permeability
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-7 Days |
| 被験者数 | 22 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44, 45-64, 65+ |
| 体型 | 平均 |
この研究の注釈：
The expected rise in intestinal permeability associated with NSAID therapy seen in otherwise healthy persons was fully blunted with coadministration of 125mL of a colostrum solution (Bioenervi) thrice daily for a week when compared to the placebo therapy of whey protein.
The expected rise in intestinal permeability associated with NSAID therapy seen in otherwise healthy persons was fully blunted with coadministration of 125mL of a colostrum solution (Bioenervi) thrice daily for a week when compared to the placebo therapy of whey protein.
Another segment of the study administering colostrum to persons who routinely took NSAIDs failed to find a beneficial effect, although this population tested also did not have elevated intestinal permeability (thought to normally occur with chronic NSAID usage).
研究の資金源に関する問題点：
Partially funded by producers of Bioenervi